Scolaris Content Display Scolaris Content Display

Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

Esta versión no es la más reciente

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the effects of single‐inhaler LABA/LAMA combinations versus placebo on clinically meaningful outcomes in patients with stable COPD.